Send feedback

ARSL p.Ala26=

c.78A>G · rs35718384 · VCV157737

Benign Multiple submitters
Classification
Benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 6 submitters
gnomAD v4.1
Common
common (popmax 22.8%, afr) — too common for a highly-penetrant pathogenic allele
Conditions
2
chondrodysplasia punctata, brachytelephalangic, autosomal

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.3GERP -0.88
Overall
CADD2.281PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 22.8% African / African-American · 13,009/57,122 alleles
Filtering AF 22.4% ClinGen BA1/BS1 input FAF95, joint · FAF99 22.3%
Overall 1.29% 15,579/1,210,324 alleles · common
Ancestry group Frequency 1 in
African / African-Americangrpmax 22.8% 4
Remaining individualsnot grpmax-eligible 1.93% 52
Admixed American 1.58% 63
Middle Eastern 1.29% 78
South Asian 0.561% 178
East Asian 0.166% 603
European (non-Finnish) 0.0551% 1,816

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ARSL
Protein
p.Ala26=
Coding
c.78A>G
MANE Select
NM_000047
dbSNP
rs35718384
Type
single nucleotide variant
Location
chrX:2958381 (GRCh38)
Structure
AlphaFold pLDDT 92.57
Full ARSL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/arsl-p-ala26 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown